|
Canadian
IP Update - Biotechnology & Pharmaceuticals
The Canadian
Biotechnology & Pharmaceutical Law Bulletin is a periodical
newsletter highlighting news and developments in Canadian
intellectual property law as they apply to pharmaceutical and
biotechnology research.
These newsletters are published by our firm from time to time to keep our
clients and
associates aware of new developments in Canadian IP law which might affect companies in
the biotechnology and pharmaceutical industries. Click on the volume numbers below
to go to those issues, on-line. To join the mailing list for these publications,
please just send us an e-mail.
- Extinguishment of compulsory license affecting sub-licensee
- Definition of medicine for notice of compliance provisions
- Relevance of patent file histories in patent infringement actions
- Nature of evidence required on injunctive relief applications in
patent infringement cases
- NEW PATENT RULES: Revision of Patent Rules led to significant changes
in Canadian Patent Law
- Upholding Ontario’s pharmaceutical price freeze
- Notice of Compliance applicant not required to answer process
questions
- New Commissioner of Patents
- Canada accedes to Budapest Treaty
- Harvard Mouse patent application rejected by the Commissioner of
Patents
- Is It a Secret? Trial judgment in drug companies trade secrets
case set aside
- Applying for Judicial Review of a Decision of the Commissioner of
Patents
- Defining "Biotechnology"
- Patented Medicines: Removal of Process Patents from the Health
Canada Notice of Compliance Patent Registry
- PMPRB to Continue to Monitor Prices following 'Dedication'
- The Novelty of Combination Patents
- Microbiological Processes for Foods and Medicines:
Patent Act
Section 39(1) expires, allowing consideration of product claims
- Canadian Plant Breeders' Rights
- Recent publications of interest
- Other issues
Top of page
| Print this page
|